GlaxoSmithKline Pharmaceuticals Limited Share Price & Technical Analysis

GLAXO · ₹2,181 (-0.36%)

Healthcare / Drug Manufacturers - General

AI Score 13 · Bearish

₹2,181

-0.36%

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases

Price chart

Seasonality

Jun has 3 positive and 2 negative years (last 5 years shown)

-1% return in Jun, 4% avg return in past 3 year Jun month.

-10% return in 2026, 26% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-3%7%-9%1%-5%-1%-10%
25-12%27%16%3%12%3%-7%-12%-5%-2%-3%-3%19%
2418%-3%-10%7%24%1%3%0%0%-1%-10%-8%20%
23-4%6%-1%-7%5%9%-2%2%9%-8%16%14%40%
22-11%-4%9%-4%-3%-2%-7%3%-2%-3%-3%-2%-30%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 13/100

Bearish · Downtrend · Oversold

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also provides specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and Trelegy Ellipta for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections; CobadexCZS to treat mineral and vitamins deficiency states; Flutivate, a skin cream for adults, children, and infants; Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis; CALPOL to treat mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment of specific bacterial skin infections; BETNOVATE for skin conditions; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin associated with redness and itch. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. The company was incorporated in 1924 and is based in Mumbai, India. GlaxoSmithKline Pharmaceuticals Limited operates as a subsidiary of GSK plc.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

₹370.80B

P/E ratio

36.37

52W high

₹3,516

52W low

₹2,154

Volume

53,249

Beta

0.10

Related stocks in Healthcare

Frequently asked questions

What is GlaxoSmithKline Pharmaceuticals Limited share price today?
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) last traded around ₹2,181 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does GLAXO have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for GLAXO. Download the app for real-time alerts.
How can I analyze GlaxoSmithKline Pharmaceuticals Limited stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro